获得性-话题@MedSci

#获得性#

170篇内容 | 3272人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2042676, encodeId=52a720426e6df, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Blood：与来那度胺/泊马度胺获得性耐药相关的多重CRBN变异！, objectType=article, longId=205835, objectId=b32b20583544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32b20583544, replyNumber=0, likeNumber=114, createdTime=2021-09-17, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32b20583544, moduleTitle=Blood：与来那度胺/泊马度胺获得性耐药相关的多重CRBN变异！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b32b20583544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042685, encodeId=5eff20426850a, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=NEJM：KRAS抑制剂获得性耐药机制研究, objectType=article, longId=213196, objectId=8eda2131962c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eda2131962c, replyNumber=0, likeNumber=68, createdTime=2021-07-24, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eda2131962c, moduleTitle=NEJM：KRAS抑制剂获得性耐药机制研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eda2131962c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042680, encodeId=1850204268074, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Eur Respir J：使用抑酸药的儿童发生社区获得性肺炎风险分析, objectType=article, longId=209242, objectId=382a209242bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=382a209242bc, replyNumber=0, likeNumber=0, createdTime=2021-10-03, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=382a209242bc, moduleTitle=Eur Respir J：使用抑酸药的儿童发生社区获得性肺炎风险分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=382a209242bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042673, encodeId=454220426e30e, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, objectType=article, longId=201780, objectId=b102201e8073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b102201e8073, replyNumber=0, likeNumber=75, createdTime=2021-03-22, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b102201e8073, moduleTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b102201e8073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042670, encodeId=ee5420426e0f9, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Blood：Emicizumab治疗获得性血友病A, objectType=article, longId=199478, objectId=3c8b1994e856, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c8b1994e856, replyNumber=0, likeNumber=88, createdTime=2021-07-13, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c8b1994e856, moduleTitle=Blood：Emicizumab治疗获得性血友病A, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c8b1994e856)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042669, encodeId=d712204266920, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Blood：与多发性骨髓瘤来那度胺或泊马度胺获得性耐药相关的CBRN变异, objectType=article, longId=199253, objectId=e69319925396, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e69319925396, replyNumber=0, likeNumber=75, createdTime=2021-06-26, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e69319925396, moduleTitle=Blood：与多发性骨髓瘤来那度胺或泊马度胺获得性耐药相关的CBRN变异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e69319925396)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042684, encodeId=764e2042684b5, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Blood：Cxcr4功能获得性突变导致滤泡外免疫反应失控！, objectType=article, longId=212693, objectId=219a21269341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=219a21269341, replyNumber=0, likeNumber=68, createdTime=2022-05-29, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=219a21269341, moduleTitle=Blood：Cxcr4功能获得性突变导致滤泡外免疫反应失控！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=219a21269341)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042678, encodeId=e80120426e865, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle= JAMA Pediatr：无需住院的儿童社区获得性肺炎患者，其抗菌疗程可缩短至5天, objectType=article, longId=208443, objectId=085320844318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=085320844318, replyNumber=0, likeNumber=115, createdTime=2021-10-02, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=085320844318, moduleTitle= JAMA Pediatr：无需住院的儿童社区获得性肺炎患者，其抗菌疗程可缩短至5天, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=085320844318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042675, encodeId=849420426e5fd, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, objectType=article, longId=204118, objectId=286220411867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286220411867, replyNumber=0, likeNumber=83, createdTime=2021-07-23, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286220411867, moduleTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=286220411867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042667, encodeId=0e59204266ea6, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Clin Respir J：根据细胞因子可以辨别社区获得性肺炎的感染原因, objectType=article, longId=198213, objectId=a8fd198213ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8fd198213ce, replyNumber=0, likeNumber=79, createdTime=2020-11-25, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8fd198213ce, moduleTitle=Clin Respir J：根据细胞因子可以辨别社区获得性肺炎的感染原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8fd198213ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042664, encodeId=4ffd20426640e, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=ATVB：COVID-19肺炎和社区获得性肺炎患者静脉血栓栓塞风险比较, objectType=article, longId=197533, objectId=ecaf19e53342, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecaf19e53342, replyNumber=0, likeNumber=66, createdTime=2020-08-17, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecaf19e53342, moduleTitle=ATVB：COVID-19肺炎和社区获得性肺炎患者静脉血栓栓塞风险比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecaf19e53342)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042677, encodeId=2bc020426e7c0, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=J Invest Dermatol：抑制糖代谢可缓解获得性大疱性类天疱疮样表皮松解症, objectType=article, longId=207467, objectId=9f5120e46784, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5120e46784, replyNumber=0, likeNumber=72, createdTime=2021-04-14, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5120e46784, moduleTitle=J Invest Dermatol：抑制糖代谢可缓解获得性大疱性类天疱疮样表皮松解症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5120e46784)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042663, encodeId=c8cf20426634e, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=社区获得性肺炎也能要命，治疗要快准狠！, objectType=article, longId=196019, objectId=313e19601956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313e19601956, replyNumber=0, likeNumber=88, createdTime=2020-11-05, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313e19601956, moduleTitle=社区获得性肺炎也能要命，治疗要快准狠！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=313e19601956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042679, encodeId=79f920426e974, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Lancet：社区获得性肺炎住院患者3天抗生素治疗病情稳定后即可停药, objectType=article, longId=209050, objectId=fa512090504a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa512090504a, replyNumber=0, likeNumber=68, createdTime=2021-10-10, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa512090504a, moduleTitle=Lancet：社区获得性肺炎住院患者3天抗生素治疗病情稳定后即可停药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa512090504a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042666, encodeId=f19720426664a, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Crit Care Med：血必净注射液治疗重症社区获得性肺炎危重病人的效果, objectType=article, longId=198200, objectId=e87419820005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e87419820005, replyNumber=0, likeNumber=92, createdTime=2021-06-09, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e87419820005, moduleTitle=Crit Care Med：血必净注射液治疗重症社区获得性肺炎危重病人的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e87419820005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042672, encodeId=d64c20426e2c0, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Oncogene：YB1/EphA2信号增强能够促进肾细胞癌获得性舒尼替尼耐药和转移潜能, objectType=article, longId=200299, objectId=6f3d2002993b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f3d2002993b, replyNumber=0, likeNumber=87, createdTime=2020-12-24, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f3d2002993b, moduleTitle=Oncogene：YB1/EphA2信号增强能够促进肾细胞癌获得性舒尼替尼耐药和转移潜能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f3d2002993b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042674, encodeId=c6d120426e460, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=JAHA：HIV感染者社区获得性肺炎与心血管事件风险, objectType=article, longId=203690, objectId=53a0203690ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53a0203690ef, replyNumber=0, likeNumber=92, createdTime=2021-02-04, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53a0203690ef, moduleTitle=JAHA：HIV感染者社区获得性肺炎与心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53a0203690ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042659, encodeId=545b204265929, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, objectType=article, longId=190910, objectId=dce919091038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dce919091038, replyNumber=0, likeNumber=76, createdTime=2020-12-03, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce919091038, moduleTitle=关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dce919091038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042660, encodeId=ee4d204266052, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=Blood：获得性血友病A（AHA）的出血风险及对止血治疗的反应, objectType=article, longId=192495, objectId=d596192495c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d596192495c5, replyNumber=0, likeNumber=73, createdTime=2020-10-17, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d596192495c5, moduleTitle=Blood：获得性血友病A（AHA）的出血风险及对止血治疗的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d596192495c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042671, encodeId=caa820426e171, content=<a href='/topic/show?id=999c88014ea' target=_blank style='color:#2F92EE;'>#获得性#</a>, objectTitle=J Thromb Haemost：视网膜血管闭塞成人遗传性或获得性血栓形成倾向, objectType=article, longId=199652, objectId=34f619965256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34f619965256, replyNumber=0, likeNumber=78, createdTime=2021-06-07, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34f619965256, moduleTitle=J Thromb Haemost：视网膜血管闭塞成人遗传性或获得性血栓形成倾向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34f619965256)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

获得性

2020-05-29

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Blood：与来那度胺/泊马度胺获得性耐药相关的多重CRBN变异！

2021-09-17

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

NEJM：KRAS抑制剂获得性耐药机制研究

2021-07-24

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Eur Respir J：使用抑酸药的儿童发生社区获得性肺炎风险分析

2021-10-03

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好

2021-03-22

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Blood：Emicizumab治疗获得性血友病A

2021-07-13

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Blood：与多发性骨髓瘤来那度胺或泊马度胺获得性耐药相关的CBRN变异

2021-06-26

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Blood：Cxcr4功能获得性突变导致滤泡外免疫反应失控！

2022-05-29

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

JAMA Pediatr：无需住院的儿童社区获得性肺炎患者，其抗菌疗程可缩短至5天

2021-10-02

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性

2021-07-23

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Clin Respir J：根据细胞因子可以辨别社区获得性肺炎的感染原因

2020-11-25

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

ATVB：COVID-19肺炎和社区获得性肺炎患者静脉血栓栓塞风险比较

2020-08-17

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

J Invest Dermatol：抑制糖代谢可缓解获得性大疱性类天疱疮样表皮松解症

2021-04-14

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

社区获得性肺炎也能要命，治疗要快准狠！

2020-11-05

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Lancet：社区获得性肺炎住院患者3天抗生素治疗病情稳定后即可停药

2021-10-10

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Crit Care Med：血必净注射液治疗重症社区获得性肺炎危重病人的效果

2021-06-09

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Oncogene：YB1/EphA2信号增强能够促进肾细胞癌获得性舒尼替尼耐药和转移潜能

2020-12-24

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

JAHA：HIV感染者社区获得性肺炎与心血管事件风险

2021-02-04

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

关于《社区获得性细菌性肺炎抗菌药物研发临床试验技术指导原则》和《急性细菌性皮肤与皮肤结构感染抗菌药物研发临床试验技术指导原则》征求意见的通知

2020-12-03

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

Blood：获得性血友病A（AHA）的出血风险及对止血治疗的反应

2020-10-17

pandamao2010 (审核中...)

前往app查看评论内容

#获得性#

J Thromb Haemost：视网膜血管闭塞成人遗传性或获得性血栓形成倾向

2021-06-07

科室
- - 订阅+
  - 更多科室
工具
服务